CCO’s programs provide the latest clinically relevant, evidence-based education & support the competence of healthcare teams #HIV#HBV#HCV#COVIDー19#IDTwitter
Join us now for a live webinar on Monkeypox in PWH where @profchloeorkin and @MonicaGandhi9 discuss making treatment decisions and answer your most pressing questions. JOIN: https://t.co/SMSMnhhQhS
#CE#CME#Monkeypox
Excited to announce the newest addition to our Clinical Education Alliance. Rockpointe has joined our team to expand our primary care offerings and outreach to underserved communities. https://t.co/wINIJwZHoV #primarycare#healthcareequity#communityhealthcare#CE#HCP#MedEd
Don't miss this live webinar on July 19th; have your questions about screening, diagnosis, and management of hepatitis delta virus (#HDV) answered by expert faculty. @Mariabutif @RobertGish
REGISTER NOW➡️https://t.co/npMGkaxBqr
#LiverTwitter#IDTwitter#TwitterRx#MedTwitter
Don't miss this live webinar on July 19th; have your questions about screening, diagnosis, and management of hepatitis delta virus (#HDV) answered by expert faculty. @Mariabutif @RobertGish
REGISTER NOW➡️https://t.co/npMGkaxBqr
#LiverTwitter#IDTwitter#TwitterRx#MedTwitter
STARTING SOON! Join Prof. Tarik Asselah today at 12:00 PM EDT as he provides rapid updates from #ILC2022 on:
✅Current #HBV management
✅#HCV treatment & implementation
✅Evolving #HDV data
✅HBV cure
REGISTER NOW➡️https://t.co/bM2basZDFm
#LiverTwitter#IDTwitter#TwitterRx
STARTING SOON! Join Prof. Tarik Asselah today at 12:00 PM EDT as he provides rapid updates from #ILC2022 on:
✅Current #HBV management
✅#HCV treatment & implementation
✅Evolving #HDV data
✅HBV cure
REGISTER NOW➡️https://t.co/bM2basZDFm
#LiverTwitter#IDTwitter#TwitterRx
Don't miss this #podcast as Prof. Pietro Lampertico discusses how to identify which patients with chronic #HBV infection may not need immediate HBV treatment & the critical need to continue monitoring such patients even in the absence of ongoing therapy➡️https://t.co/fpkBIsAZs2
#POLL In your experience, what barriers to #HBV care do your patients experience in the clinical setting?
Learn from Dr. Mindie Nguyen & Jennifer Wild as they discuss their experiences with barriers to HBV care & actions to reduce those barriers in 🇺🇸➡️https://t.co/mP6sssZOD4
Don't miss this #podcast as Prof. Pietro Lampertico discusses how to identify which patients with chronic #HBV infection may not need immediate HBV treatment & the critical need to continue monitoring such patients even in the absence of ongoing therapy➡️https://t.co/fpkBIsAZs2
#POLL In your experience, what barriers to #HBV care do your patients experience in the clinical setting?
Learn from Dr. Mindie Nguyen & Jennifer Wild as they discuss their experiences with barriers to HBV care & actions to reduce those barriers in 🇺🇸➡️https://t.co/mP6sssZOD4
STARTING SOON! Join Prof. Stefan Zeuzem today as he provides rapid updates on current #HBV management, #HCV treatment and implementation, evolving #HDV data, and HBV cure from #ILC2022.
REGISTER NOW➡️https://t.co/5ZCc6fmU2O
#LiverTwitter#IDTwitter#TwitterRx#MedTwitter
STARTING SOON! Join Prof. Stefan Zeuzem today as he provides rapid updates on current #HBV management, #HCV treatment and implementation, evolving #HDV data, and HBV cure from #ILC2022.
REGISTER NOW➡️https://t.co/5ZCc6fmU2O
#LiverTwitter#IDTwitter#TwitterRx#MedTwitter
Don't miss this #webinar tomorrow, June 28th, as Prof.
Stefan Zeuzem provides rapid updates on current #HBV
management, #HCV treatment and implementation,
evolving #HDV data, and HBV cure from #ILC2022.
REGISTER NOW➡️https://t.co/jPgSQyrmno
#LiverTwitter#IDTwitter#TwitterRx
Don't miss this #webinar tomorrow, June 28th, as Prof.
Stefan Zeuzem provides rapid updates on current #HBV
management, #HCV treatment and implementation,
evolving #HDV data, and HBV cure from #ILC2022.
REGISTER NOW➡️https://t.co/jPgSQyrmno
#LiverTwitter#IDTwitter#TwitterRx
Dr Michelle Collins-Ogle discusses key considerations
for ART management for transgender PWH, including:
✅providing care within gender-affirmative care model
✅drug-drug interactions btw hormone therapy & ART
✅barriers to engagement & retention in care
➡️https://t.co/s5tFjyYI73
STILL TIME TO REGISTER! Join Prof. Tarik Asselah today as he provides rapid updates from #ILC2022 on:
✅Current #HBV management
✅#HCV treatment & implementation
✅Evolving #HDV data
✅HBV cure
REGISTER NOW➡️https://t.co/yOFJLp1IB3
#LiverTwitter#IDTwitter#TwitterRx
STILL TIME TO REGISTER! Join Prof. Tarik Asselah today as he provides rapid updates from #ILC2022 on:
✅Current #HBV management
✅#HCV treatment & implementation
✅Evolving #HDV data
✅HBV cure
REGISTER NOW➡️https://t.co/yOFJLp1IB3
#LiverTwitter#IDTwitter#TwitterRx
Dr Michelle Collins-Ogle discusses key considerations
for ART management for transgender PWH, including:
✅providing care within gender-affirmative care model
✅drug-drug interactions btw hormone therapy & ART
✅barriers to engagement & retention in care
➡️https://t.co/s5tFjyYI73
In this case example presented by Dr. Milena Murray (@milenaPharmD), learn the latest data about maternal weight gain associated with ART use in pregnancy, including pregnancy effects and the role of baseline maternal weight➡️https://t.co/N2fI29rNM0
#HIV#IDTwitter#MedTwitter